Drozitumab

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Drozitumab ?
Monoclonal antibody
Type Whole antibody
Source Human
Target DR5
Clinical data
Legal status ?
Identifiers
CAS number 912628-39-8 N
ATC code None
UNII SQ67484MA7 YesY
Chemical data
Formula C6334H9792N1700O2000S42 
Mol. mass 143.1 kDa
 N (what is this?)  (verify)

Drozitumab is a human monoclonal antibody designed for the treatment of cancers.[1]

Drozitumab was developed by Genentech.

References[edit]

  1. ^ "Statement On A Nonproprietary Name Adopted By The USAN Council: Drozitumab". American Medical Association.